BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38342251)

  • 1. Unlocking the potential of Escherichia coli K-12: A novel approach for malignancy reduction in colorectal cancer through gene expression modulation.
    Rohani Z; Sazegar H; Rahimi E
    Gene; 2024 May; 906():148266. PubMed ID: 38342251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
    Xiong Y; You W; Wang R; Peng L; Fu Z
    Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
    Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
    World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and pathways in lung metastatic colorectal cancer.
    Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
    BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.
    Qiu X; Cheng SH; Xu F; Yin JW; Wang LY; Zhang XY
    J Cancer; 2020; 11(8):2348-2359. PubMed ID: 32127961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Signatures in Colorectal Cancer Progression.
    Ershov P; Poyarkov S; Konstantinova Y; Veselovsky E; Makarova A
    Curr Mol Med; 2023; 23(3):239-249. PubMed ID: 35490318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
    Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
    Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of endogenous RNA regulatory network for colorectal cancer based on bioinformatics.
    Li Y; Yuan F; Lin Z; Pan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):416-430. PubMed ID: 35545337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.
    Mo X; Su Z; Yang B; Zeng Z; Lei S; Qiao H
    Oncol Lett; 2020 Jan; 19(1):177-186. PubMed ID: 31897128
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang Y; Zhao J; Fu G; Sheng C; Zhu J; Zhong T; Yang F; Jiang Z
    Transl Cancer Res; 2022 Oct; 11(10):3686-3697. PubMed ID: 36388015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
    Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
    J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer.
    Sadat Kalaki N; Ahmadzadeh M; Najafi M; Mobasheri M; Ajdarkosh H; Karbalaie Niya MH
    Biochem Biophys Rep; 2024 Mar; 37():101633. PubMed ID: 38283191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer.
    Mahmoodi Chalbatani G; Gharagouzloo E; Malekraeisi MA; Azizi P; Ebrahimi A; Hamblin MR; Mahmoodzadeh H; Elkord E; Miri SR; Sanati MH; Panahi B
    Sci Rep; 2023 Nov; 13(1):19454. PubMed ID: 37945594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and
    Guo M; Li X; Li J; Li B
    Heliyon; 2023 Jun; 9(6):e17101. PubMed ID: 37389063
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chen D; Qin Y; Dai M; Li L; Liu H; Zhou Y; Qiu C; Chen Y; Jiang Y
    Cancer Manag Res; 2020; 12():13051-13069. PubMed ID: 33376399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.